Suchergebnisse - "Sexton, Wade J"

PubPharm (5)

1

Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re : E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274

enthalten in: European urology oncology | 2024

von Abel, E. | Master, V. | Spiess, P. | +9

2

The Selection for Cytoreductive Nephrectomy (SCREEN) Score : Improving Surgical Risk Stratification by Integrating Common Radiographic Features

enthalten in: European urology oncology | 2024

von Abel, E. | Master, V. | Spiess, P. | +9

3

Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer

enthalten in: European urology oncology | 2024

von Li, R. | Nocera, L. | Rose, K. | +15

4

Re : Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610

enthalten in: European urology oncology | 2023

von Shapiro, D. | Karam, J. | Master, V. | +4

CommentOn: Eur Urol Oncol. 2023 Dec;6(6):604-610. - PMID 37005212

5

Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria

enthalten in: European urology oncology | 2021

von Valenberg, F. | Hiar, A. | Wallace, E. | +29

1
[1]